Research Paper Volume 12, Issue 17 pp 17167—17208
SNAI1 is a prognostic biomarker and correlated with immune infiltrates in gastrointestinal cancers
Figure 1. The six EMT markers expression levels in different types of human cancers. (A) Increased or decreased six EMT markers in datasets of different cancers compared with normal tissues in the Oncomine database. (B) SNAI1 expression levels in different tumor types from TCGA database were determined by TIMER (*P < 0.05, **P <0.01, ***P < 0.001). (C–E) Correlation of SNAI1 expression and immune subtypes (wound healing, IFN-gamma dominant, inflammatory, lymphocyte depleted, TGF-β dominant) in COAD (colon adenocarcinoma), READ (rectum adenocarcinoma), and STAD (stomach adenocarcinoma).